Popular
How I Triple My Returns With 3x Leveraged...
How to Find Compelling Charts in Every Sector
EVs Now Emit 73 percent Less Than Gasoline...
Cygnus Metals Limited: Issue of Performance Rights
FPX Nickel Announces Share-Based Compensation Grant
Blue Lagoon Resources Officially Opens Dome Mountain Gold...
At least four killed and many ‘kidnapped’ in...
Universities threatened with funding cuts under proposed plan...
A piece of the illegally felled Sycamore Gap...
EU’s von der Leyen survives parliament confidence vote...
  • Home
HotInvestingPilots.com
  • Politics
  • World News
  • Stock
  • Investing
Stock

The SCTR Report: Insmed’s Stock Hangs in the Balance—Here’s What You Need to Know

by September 13, 2024
written by September 13, 2024

Numerous companies are making strides within their respective sectors, but, unless you follow the sector closely, you might not be aware of them. That’s what makes StockCharts Technical Rank (SCTR) reports so helpful.

If you’ve checked your SCTR reports regularly, you might have noticed Insmed (INSM) appear at or near the top over the last three months.

FIGURE 1. DAILY SCTR REPORTS SHOW INSM IN THE OF THE TOP-UP, LARGE-CAP STOCKS.Image source: StockCharts.com. For educational purposes.

Insmed (INSM) is a biotech company that has had a near-perfect SCTR score of 99.9 since the end of May.

A SCTR (pronounced scooter) score above 90 is exceedingly bullish, as it signals technical strength across multiple technical indicators and timeframes. Sustaining a score well above 90 for months tells you that something tremendous is happening with the company and its stock.

But if you don’t follow biotech, you’re probably wondering, “What is Insmed? Why haven’t I heard of it? Why is it soaring now? Where was it before it showed up on the SCTR report’s top spot?”

In a Nutshell, Here’s What’s Driving INSM

Insmed’s stock is popping thanks to positive results from a late-stage study of its antibiotic drug Arikayce, developed for treating a rare, severe lung infection. The study’s success boosts hopes for broader FDA approval, driving INSM’s sharp breakaway gap to all-time highs.

Before this, however, what did INSM’s performance look like?

Three-Year Lookback at INSM’s Performance

FIGURE 2. WEEKLY CHART OF INSM. The recent tests catapulted INSM to all-time highs.Chart source: StockCharts.com. For educational purposes.

Take note of the following points:

  • The breakaway gap (see orange short-term downsloping trend line) from $22 to $49.53 marked a 125% spike.
  • While INSM’s SCTR score has exceeded the 90 line four times in the last three years (see green circles), notice how it barely outperformed, and largely underperformed, its broader industry, represented by the Dow Jones U.S. Biotechnology Index ($DJUSBT).
  • The latest break above the 90 line looks flat-out bullish (see green rectangle), aligning with a 171% outperformance of its industry.

Does this make INSM a strong candidate for a long position? To explore that further, let’s shift to a daily chart.

Should You Go Long INSM?

FIGURE 3. DAILY CHART OF INSM. Note the declining momentum and topping formation.Chart source: StockCharts.com. For educational purposes.

Here are the main things to keep an eye on:

  • INSM looks to be forming a double top; still, market sentiment reacting to INSM’s latest testing news and developments moving forth may defy (bearish) technical indications.
  • The Chaikin Money Flow (CMF) shows that buying pressure is fading, matching up with the Relative Strength Index’s (RSI’s) bearish divergence signal from overbought levels.
  • Despite looking toppy, for INSM’s near-term uptrend to continue, you’d want to see it break above resistance at its all-time level of $80.53 while remaining above its most recent swing low at the $70 range.
  • If it falls below the $70 range, the next lines of support can be at the previous swing lows of $67.20 and $61.50.

Warning: A deeper correction may indicate that something is off between the technical reading and the market’s reaction to the company’s news or product development.

If INSM falls below $61.50, the long-term uptrend could still hold despite invalidating the short-term trend. Be extra careful, though! INSM might slide to $45–$52, hitting key Fibonacci retracement levels, but a dip that low could mean something big has changed with INSM’s product development, and the price action may be reflecting the market’s response to these (bearish) developments.

Closing Bell

StockCharts’ SCTR Reports spotlight hidden stock opportunities that might not have crossed your radar. Insmed is a great example. It’s been riding high on positive testing news, but its technicals are flashing warning signs. If you want to follow INSM’s price action, add it to one of your StockCharts ChartLists. If not, be sure to use SCTR daily to find other (potentially hidden) opportunities for your next trade.


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

0 comment
0
FacebookTwitterPinterestEmail

previous post
A Déjà Vu in The Consumer Staples Sector Sends a Strong Warning Signal
next post
Hamas leader sends letters from hiding after almost a year of silence

Related Articles

How I Triple My Returns With 3x Leveraged...

July 11, 2025

How to Find Compelling Charts in Every Sector

July 11, 2025

Breakout Watch: One Stock in Each Sector to...

July 10, 2025

Small Caps Are Rotating In — Here’s Why...

July 10, 2025

Want Faster, Lower Risk Trades? Use This Setup

July 10, 2025

The Seasonality Trend Driving XLK and XLI to...

July 10, 2025

Tariff Shock Spurs “Buy-the-Dip” Setups in Tesla and...

July 9, 2025

The Best Five Sectors, #26

July 8, 2025

Don’t Overlook This Lagging Industry; I Believe It’s...

July 7, 2025

Week Ahead: NIFTY Set To Stay In A...

July 5, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • How I Triple My Returns With 3x Leveraged ETFs!

    July 11, 2025
  • How to Find Compelling Charts in Every Sector

    July 11, 2025
  • EVs Now Emit 73 percent Less Than Gasoline Cars Over Their Lifetime, Says ICCT Study

    July 11, 2025
  • Cygnus Metals Limited: Issue of Performance Rights

    July 11, 2025
  • FPX Nickel Announces Share-Based Compensation Grant

    July 11, 2025
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 hotinvestingpilots.com | All Rights Reserved

HotInvestingPilots.com
  • Politics
  • World News
  • Stock
  • Investing